abstract |
An Ankara modified vaccine virus (MVA) for use in a method of immunizing an animal, including a human, to protect it against smallpox infection within 2-7 days after immunization, in which a protective immune response is generated against smallpox in 2-7 days after immunization, and in which the MVA is MVA-BN. |